Zhongchao renews contract with China Association for Health Promotion and Education and GlaxoSmithKline

SHANGHAI, March 17, 2021 / PRNewswire / – Zhongchao Inc. (NASDAQ: ZCMD) (“Zhongchao” or the “Company”), a healthcare services company providing patient management, online healthcare information, vocational training and educational services, announced today hui the renewal of its partnership with the Chinese Association for the Promotion and Education in Health and GlaxoSmithKline (China) Investment Limited to continue the “Pulmonary Arterial Hypertension Online Course – Connections with Famous Hospitals” (“HAP Project”) medical education program in 2021.

The PAH project aims to promote the implementation of the multidisciplinary pulmonary hypertension treatment model and improve the ability of physicians to solve clinical problems. In 2020, more than 200 pulmonary hypertension experts participated in the PAH project, training a total of 10,000 clinicians. In 2021, we expect more clinicians to participate in PAH Project aimed at obtaining training for updating knowledge, learning skills and exchanging experiences in pulmonary hypertension.

Weiguang Yang, Chairman of the Board and Chief Executive Officer of Zhongchao, said: “In relation to the population and the number of patients potentially with pulmonary hypertension in China, the number of doctors specializing in the diagnosis and treatment of this area is very limited. As a result, our PAH project in 2020 received a positive response and recognition from the majority of clinicians. The success of the PAH project brings us valuable experiences in rare disease education. We believe that we will attract more social and business cooperation in promoting rare disease education to further develop our business. ”

About Zhongchao Inc.

Incorporated in 2012 with the head office at Shanghai and Beijing, China, Zhongchao Inc. is an online provider of health information is an online provider of health information, vocational training and educational services to health professionals under its platform “MDMOOC” (www.mdmooc.org) and to the public through its “Sunshine Health Forums” platform (www.ygjkclass.com) in China. The Company also offers patient management services under its “Zhongxun” platform (www.zhongxun.online). Further information on the Company is available on its investor relations website at http://izcmd.com.

Safe Harbor Declaration

This press release contains forward-looking statements as defined by the Private Securities Litigation Reform Act of 1995. Forward-looking statements include statements regarding future plans, objectives, goals, strategies, events or performance, and assumptions underlying statements and other statements that are other than statements of historical fact. When the Company uses words such as “may”, “will”, “intention”, “should”, “believe”, “expect”, “anticipate”, “plan”, “estimate” or Similar phrases that do not relate only to matters, it makes forward-looking statements. Forward-looking statements are not guarantees of future performance and involve risks and uncertainties which may cause actual results to differ materially from the Company’s expectations discussed in the forward-looking statements. These statements are subject to uncertainties and risks, including, but not limited to the following: the objectives and strategies of the Company; the future business development of the Company; demand and acceptance of products and services; technological changes; economic conditions; the growth of the vocational training and educational services market in China and other international markets that the Company plans to serve; reputation and brand; the impact of competition and pricing; government regulations; fluctuations in general economic and business conditions in China and in the international markets that the Company intends to serve and the assumptions underlying or related to any of the aforementioned risks and other risks contained in reports filed by the Company with the SEC, the duration and severity of the recent coronavirus outbreak, including its impacts on all of our business and operations. For these and other reasons, investors are cautioned not to place undue reliance on any forward-looking statements contained in this press release. Additional factors are discussed in the Company’s filings with the SEC, which are available for review at www.sec.gov. The Company assumes no obligation to publicly revise these forward-looking statements to reflect events or circumstances that arise after the date hereof.

For more information please contact:

In the business:
Pei Xu, Chief Financial Officer
E-mail: [email protected]
Phone: +86 21-3220-5987

Investor Relations:
Sherry Zheng
Weitian Group SARL
E-mail: [email protected]
Telephone: +1 718-213-7386

SOURCE Zhongchao Inc.

Comments are closed.